Paul Tudor Jones's OFIX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 262,974 shares of Orthofix Medical Inc. (OFIX) worth $3.02 M, representing 0.01% of the portfolio. First purchased in 2018-Q4, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in OFIX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 158,197 shares. Largest reduction occurred in Q2 2025, reducing 121,720 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Orthofix Medical (OFIX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Orthofix Medical (OFIX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +60,368 | Add 29.80% | 262,974 | $11.47 |
| Q4 2025 | -14,438 | Reduce 6.65% | 202,606 | $15.16 |
| Q3 2025 | +158,197 | Add 268.83% | 217,044 | $14.64 |
| Q2 2025 | -121,720 | Reduce 67.41% | 58,847 | $11.15 |
| Q1 2025 | +47,037 | Add 35.23% | 180,567 | $16.31 |
| Q4 2024 | +270 | Add 0.20% | 133,530 | $17.46 |
| Q3 2024 | +1,994 | Add 1.52% | 133,260 | $15.62 |
| Q2 2024 | +35,469 | Add 37.03% | 131,266 | $13.26 |
| Q1 2024 | +49,049 | Add 104.92% | 95,797 | $14.52 |
| Q4 2023 | +46,748 | New Buy | 46,748 | $13.48 |
| Q1 2023 | -35,029 | Sold Out | 0 | $0.00 |
| Q4 2022 | -14,904 | Reduce 29.85% | 35,029 | $0.02 |
| Q3 2022 | +17,722 | Add 55.02% | 49,933 | $19.11 |
| Q2 2022 | +18,101 | Add 128.28% | 32,211 | $23.53 |
| Q1 2022 | -18,841 | Reduce 57.18% | 14,110 | $32.67 |
| Q4 2021 | +10,233 | Add 45.04% | 32,951 | $31.08 |
| Q3 2021 | -7,661 | Reduce 25.22% | 22,718 | $38.12 |
| Q2 2021 | +12,273 | Add 67.78% | 30,379 | $40.13 |
| Q1 2021 | +9,063 | Add 100.22% | 18,106 | $43.36 |
| Q4 2020 | -12,190 | Reduce 57.41% | 9,043 | $43.02 |
| Q3 2020 | +3,926 | Add 22.68% | 21,233 | $31.13 |
| Q2 2020 | -5,447 | Reduce 23.94% | 17,307 | $32.01 |
| Q1 2020 | +7,399 | Add 48.19% | 22,754 | $28.00 |
| Q4 2019 | +15,355 | New Buy | 15,355 | $46.17 |
| Q2 2019 | -11,258 | Sold Out | 0 | $0.00 |
| Q1 2019 | +1,388 | Add 14.06% | 11,258 | $56.40 |
| Q4 2018 | +9,870 | New Buy | 9,870 | $52.48 |
Paul Tudor Jones's Orthofix Medical Investment FAQs
Paul Tudor Jones first purchased Orthofix Medical Inc. (OFIX) in Q4 2018, acquiring 9,870 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Orthofix Medical Inc. (OFIX) for 27 quarters since Q4 2018.
Paul Tudor Jones's largest addition to Orthofix Medical Inc. (OFIX) was in Q3 2025, adding 217,044 shares worth $3.18 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 262,974 shares of Orthofix Medical Inc. (OFIX), valued at approximately $3.02 M.
As of the Q1 2026 filing, Orthofix Medical Inc. (OFIX) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Orthofix Medical Inc. (OFIX) was 262,974 shares, as reported at the end of Q1 2026.